The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.
iShares Biotechnology ETF IBB
Morningstar’s Analysis IBB
Will IBB outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 50.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Amgen Inc | 8.47 | 597.6 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 8.18 | 577.1 Mil | Healthcare |
Gilead Sciences Inc | 8.16 | 575.1 Mil | Healthcare |
Regeneron Pharmaceuticals Inc | 8.09 | 570.1 Mil | Healthcare |
IQVIA Holdings Inc | 4.38 | 308.5 Mil | Healthcare |
Moderna Inc | 3.70 | 261.0 Mil | Healthcare |
Biogen Inc | 2.99 | 211.0 Mil | Healthcare |
Mettler-Toledo International Inc | 2.76 | 194.8 Mil | Healthcare |
Illumina Inc | 1.98 | 139.6 Mil | Healthcare |
argenx SE ADR | 1.98 | 139.4 Mil | Healthcare |